President Donald Trump, who has been promising big changes at FDA, said he has a "fantastic person" lined up for the role of FDA commissioner that will be named soon.
The likely candidates, as reported by Business Insider, include Jim O'Neill, Dr. Scott Gottlieb, and Dr. Joseph Gulfo.
Jim O'Neill, managing director at Mithril Capital, a libertarian who has said he's in favor of approving drugs that are safe, before they're shown to be effective.
Dr. Scott Gottlieb, a resident fellow at the American Enterprise Institute and former deputy commissioner of the FDA during George W. Bush's presidency. Gottlieb has emerged as a favorite among drug executives.
Dr. Joseph Gulfo, a former biotech executive who advocates for a color-coded approval system.
Latest from Quality Assurance & Food Safety
- Director General of IICA and Senior USDA Officials Meet to Advance Shared Agenda
- EFSA and FAO Sign Memorandum of Understanding
- Ben Miller Breaks Down Federal Cuts, State Bans and Traceability Delays
- Michigan Officials Warn Recalled ByHeart Infant Formula Remains on Store Shelves
- Puratos USA to Launch First Professional Chocolate Product with Cultured Cocoa
- National Restaurant Association Announces Federal Policy Priorities
- USDA Offloads Washington Buildings in Reorganization Effort
- IDFA Promotes Andrew Jerome to VP of Strategic Communications and Executive Director of Foundation
